483 Richard De La Garza, II, Ph.D Jan 2012

483 Richard De La Garza, II, Ph.D Jan 2012

Andrea Branche FDA$119.00 - Available Now

FDA investigators audited the Richard De La Garza, II, Ph.D - Houston, TX, United States facility and issued inspectional observations (via FDA 483) on 23 Jan 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 23 Jan 2012
  • Location: Houston, United States
  • FEI: 3009139723
Add To Cart